TARGETING FANCD2 TRAFFICKINGAS A NOVEL STRATEGY FOR TREATMENT OF OVARIAN CANCER

被引:0
|
作者
Pejovic, T. [1 ]
Schloff, E. [1 ]
Moffitt, M. [1 ]
De Geest, K. [1 ]
Mhawech-Fauceglia, P. [2 ]
机构
[1] OHSU, Ob Gyn, Portland, OR USA
[2] Univ So Calif, Pathol, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ESGO-1551
引用
收藏
页码:1468 / 1468
页数:1
相关论文
共 50 条
  • [31] Targeting citrate as a novel therapeutic strategy in cancer treatment
    Huang, Lan
    Wang, Cindy
    Xu, Huaxi
    Peng, Guangyong
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2020, 1873 (01):
  • [32] Targeting epigenetic plasticity as novel strategy for cancer treatment
    Kondo, Yutaka
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S48 - S48
  • [33] FANCD2 expression affects platinum response and further characteristics of high grade serous ovarian cancer in cells with different genetic backgrounds
    Taylor, Sarah J.
    Hollis, Robert L.
    Gourley, Charlie
    Herrington, Simon
    Langdon, Simon P.
    Arends, Mark J.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2024, 138
  • [34] GENOTYPING FANCONI ANEMIA PATIENTS FROM SERBIA REVEALS THREE NOVEL FANCD2 VARIANTS
    Filipovic Trikovic, Jelena
    Mandusic, Vesna
    Joksic, Ivana
    Vujic, Dragana
    Valenta Sobot, Ana
    Joksic, Gordana
    GENETIKA-BELGRADE, 2017, 49 (02): : 559 - 572
  • [35] Nuclear receptors regulate alternative lengthening of telomeres through a novel noncanonical FANCD2 pathway
    Xu, Mafei
    Qin, Jun
    Wang, Leiming
    Lee, Hui-Ju
    Kao, Chung-Yang
    Liu, Dan
    Zhou Songyang
    Chen, Junjie
    Tsai, Ming-Jer
    Tsai, Sophia Y.
    SCIENCE ADVANCES, 2019, 5 (10):
  • [36] Fanconi anemia complementation group D2 (fancd2) knockout mice display microphthalmia and an increased susceptibility to breast and ovarian cancer.
    Houghtaling, S
    Timmers, C
    Meyn, S
    Noll, M
    Reifsteck, C
    Olson, S
    Jones, S
    Finegold, M
    Grompe, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 164 - 164
  • [37] Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice
    Houghtaling, S
    Timmers, C
    Noll, M
    Finegold, MJ
    Jones, SN
    Meyn, MS
    Grompe, M
    GENES & DEVELOPMENT, 2003, 17 (16) : 2021 - 2035
  • [38] Targeting histones for degradation in cancer cells as a novel strategy in cancer treatment
    Yin, Yesheng
    Zhu, Qianqian
    Jiang, Tianxia
    Fan, Libin
    Qiu, Xiaobo
    SCIENCE CHINA-LIFE SCIENCES, 2019, 62 (08) : 1078 - 1086
  • [39] Targeting histones for degradation in cancer cells as a novel strategy in cancer treatment
    Yesheng Yin
    Qianqian Zhu
    Tianxia Jiang
    Libin Fan
    Xiaobo Qiu
    Science China(Life Sciences), 2019, 62 (08) : 1078 - 1086
  • [40] Targeting histones for degradation in cancer cells as a novel strategy in cancer treatment
    Yesheng Yin
    Qianqian Zhu
    Tianxia Jiang
    Libin Fan
    Xiaobo Qiu
    Science China Life Sciences, 2019, 62 : 1078 - 1086